Xnerve Medical was founded in 2019 by Dr. Rohan Hoare, Dr. Robert Rennaker, and Enrique Vega, combining decades of expertise in the medical device industry and a proven history of successful startups. With a shared vision, they established Xnerve with the mission to become the global leader in the treatment of neurological injuries and disabilities.
In 2024, Xnerve successfully completed two randomized controlled trials that provide robust evidence supporting the safety and efficacy of their innovative device and therapy. At the forefront of their technology, they manufacture the world’s smallest wireless vagus nerve stimulator and designed tools to enable at-home rehabilitation, ensuring that recovery integrates seamlessly into daily life.
In 2025, Xnerve Medical will spin out ReWired Medical, a company dedicated to improving the quality of life for individuals with spinal cord injuries (SCI). They are set to initiate a pivotal clinical trial in 2025, with completion expected by 2028. ReWired Medical will generate a sustained revenue stream, which will be reinvested into developing new therapies for SCI patients. A portion of the company’s net profits will be allocated to an evergreen fund, supporting both investors and nonprofit organizations that share their vision.
Additionally, in 2025, they will launch Neuwire Medical, a company focused on enhancing the lives of individuals with motor deficits resulting from stroke. With plans to initiate a pivotal trial in 2025 and complete it by 2028, they anticipate Neuwire will rapidly capture a significant share of the stroke rehabilitation market. Their implantable solution offers superior technology compared to traditional wired stimulators, positioning Neuwire to become a market leader. Given the size of the stroke market and the unmet need, Neuwire Medical is expected to potentially go public shortly after securing FDA approval.
With an unparalleled portfolio of indications, cutting-edge technology, and a strong intellectual property base, Xnerve Medical offers a unique opportunity for those passionate about advancing treatments for neurological injuries and improving the lives of individuals around the world.
